» Articles » PMID: 21696415

BRAF-KIAA1549 Fusion Transcripts Are Less Frequent in Pilocytic Astrocytomas Diagnosed in Adults

Overview
Specialty Neurology
Date 2011 Jun 24
PMID 21696415
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Duplication of 7q34 resulting in generation of BRAF-KIAA1549 fusion transcripts is a characteristic event in pilocytic astrocytoma that may also aid distinction from diffuse astrocytic tumours. As data on BRAF-KIAA1549 fusion transcript status remain mainly limited to children, we aimed to examine the diagnostic value of BRAF-KIAA1549 fusion transcripts across all age groups.

Methods: BRAF-KIAA1549 fusion transcript status was examined using reverse transcription polymerase chain reaction on formalin-fixed paraffin-embedded samples of 105 primary pilocytic astrocytomas [median patient age: 17 years (1-74 years)].

Results: Informative results (distinct wildtype BRAF bands detectable) were obtained in 105/124 cases (85%). Fusion transcripts were detected in 53 of cases (51%). They were more often encountered in tumours of infratentorial location [42/67 (63%) vs. 11/38 (29%)] and comprised KIAA1549-Ex16_BRAF-Ex9 (32 cases), KIAA1549-Ex15_BRAF-Ex9 (14 cases) and KIAA1549-Ex16_BRAF-Ex11 (seven cases). Fusion transcripts were present in 79% of tumours diagnosed in the first decade of life, but only in 51% of patients aged 11-20 years, 42% of patients aged 21-30 years, 30% of patients aged 31-40 years and 7% of patients older than 40 years. On multivariate logistic regression analysis, the association of fusion transcript status and age was confirmed adjusting for tumour location (P = 0.006).

Conclusions: The frequency of BRAF-KIAA1549 fusion transcripts is significantly lower in adult patients with pilocytic astrocytoma, weakening the sensitivity of this specific diagnostic marker in that age group.

Citing Articles

A bibliometric analysis of research trends and hotspots of pilocytic astrocytoma from 2004 to 2023.

Liang Q, Wu Z, Zhu S, Du Y, Cheng Z, Chen Y Neurosurg Rev. 2024; 48(1):3.

PMID: 39724457 PMC: 11671565. DOI: 10.1007/s10143-024-03139-9.


Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.

Wang W, Lian B, Xu C, Wang Q, Li Z, Zheng N Innovation (Camb). 2024; 5(6):100661.

PMID: 39529955 PMC: 11551471. DOI: 10.1016/j.xinn.2024.100661.


Specifics of spinal neuropathology in the molecular age.

Kresbach C, Hack K, Ricklefs F, Schuller U Neurooncol Adv. 2024; 6(Suppl 3):iii3-iii12.

PMID: 39430396 PMC: 11485660. DOI: 10.1093/noajnl/vdad127.


MEK Inhibition in a Pilocytic Astrocytoma With a Rare Mutation in a Young Adult Patient: A Case Report.

Roberto K, Keith J, Levine A, Pirouzmand F, Soliman H, Lim-Fat M JCO Precis Oncol. 2024; 8:e2400174.

PMID: 38905571 PMC: 11371098. DOI: 10.1200/PO.24.00174.


Rare vermian pilocytic astrocytoma with recurrent spontaneous hemorrhage in the elderly: A case report and review of literature.

Francis C, Kanaya K, Nagamine K, Goto T, Horiuchi T, Ohaegbulam S Surg Neurol Int. 2024; 15:90.

PMID: 38628526 PMC: 11021065. DOI: 10.25259/SNI_978_2023.